about
Toxicity of MRI and CT contrast agentsRenal protection in cardiovascular surgeryRisk prediction models for contrast induced nephropathy: systematic reviewProphylaxis of contrast-induced nephrotoxicitySubclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity.Impact of the interval between coronary angiography and off-pump coronary bypass surgery on postoperative renal function.Contrast-induced nephropathy in patients undergoing intravenous contrast-enhanced computed tomography in Korea: a multi-institutional study in 101487 patientsNeutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury.Does this adult patient have a blunt intra-abdominal injury?Kidney injury biomarkers in hypertensive, diabetic, and nephropathy rat models treated with contrast media.Albuminuria and estimated glomerular filtration rate independently associate with acute kidney injury.The role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trials.Diastolic dysfunction is associated with an increased risk of contrast-induced nephropathy: a retrospective cohort studyThe prevention of acute kidney injury an in-depth narrative review: Part 2: Drugs in the prevention of acute kidney injury.Plasma neutrophil gelatinase-associated lipocalin (NGAL) as an early predictive marker of contrast-induced nephropathy in hospitalized patients undergoing computed tomographyN-acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: a systematic review and meta-analysis.Preventing radiocontrast-induced nephropathy in chronic kidney disease patients undergoing coronary angiography.Renal Protective Effect of Probucol in Rats with Contrast-Induced Nephropathy and its Underlying Mechanism.Effectiveness of N-Acetylcysteine for the Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsEffect of N-acetyl cysteine in prevention of contrast nephropathy on patients under intravenous pyelography and contrast CTContrast-induced nephropathy--a review of current literature and guidelines.Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: a retrospective cohort study of 7977 patients at mayo clinicContrast-induced nephropathy following angiography and cardiac interventionsNon-contrast 3D time-of-flight magnetic resonance angiography for visualization of intracranial aneurysms in patients with absolute contraindications to CT or MRI contrast.Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy"Contrast nephropathy" in renal transplantation: Is it real?Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis.The protective effect of single dose tadalafil in contrast-induced nephropathy: an experimental study.Nephrotoxicity of contrast media and protective effects of acetylcysteine.Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.N-acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Narrative Review.Contrast-induced kidney injury: mechanisms, risk factors, and prevention.A critical appraisal of intravenous fluids: from the physiological basis to clinical evidence.Neutrophil gelatinase-associated lipocalin (NGAL): a promising biomarker of contrast-induced nephropathy after computed tomography.Contrast media viscosity versus osmolality in kidney injury: lessons from animal studies.Accuracy of point-of-care serum creatinine devices for detecting patients at risk of contrast-induced nephropathy: a critical overview.Statins in the prevention of contrast-induced nephropathy.Physicochemical properties of radiographic contrast media, potential nephrotoxicity and prophylaxis.Understanding and preventing contrast-induced acute kidney injury.
P2860
Q22306013-4C5FA763-5509-482B-B9BC-AF0E6C5D3AB1Q26753127-1FDC6F13-6988-4527-869F-37BA4ABB127DQ26796473-0F00B96F-9685-454F-A422-489C57B1551EQ27012899-E9F16D57-80C2-43D5-A442-E6A30F20B709Q30879334-43302ACC-C83E-460E-ABE6-6A3ED8284910Q33305487-62F09C38-8BEF-4200-9631-DDC1637E378BQ33861539-DADFDCF5-69E4-46D8-86EF-3F89D4DE0CE4Q33929305-52CD2BBA-3E68-4F69-AA35-631147D91B3FQ33945154-DC48F667-CB3F-4495-83CF-8D0E28509CF6Q34229453-D06D49F8-738C-4E75-A176-52BBBF2C4713Q34453548-CFDB8635-A5BD-4664-A4C7-EFF523303C68Q34455487-4AD287E0-ABDC-41B9-BEEB-15F499EDE696Q34661076-95F9440E-E35C-4D15-A67D-75A20E4DA04BQ34816125-7848E704-106D-4478-AC5B-9E68C412E279Q35574190-7D842B69-F486-4E47-B9CC-B372F3AF79F8Q35626471-6552E9C3-9B91-4E9A-8B36-150ECBC4A01FQ35803600-863DE774-004D-48DC-BF47-22765AC14822Q35999430-5D0A6AAF-6204-4E40-9133-71B7073CF15FQ36107057-116BA2EE-16FF-4C60-8CC6-13A81AE6281AQ36143434-8C242FD1-5DD9-415B-8345-2B97155796E3Q36425063-02299436-A14E-4154-954F-1F52DF7B3723Q36576632-C66BBC0E-D683-457D-B428-9B04C29B3E2DQ36666993-9CC1A2F0-1D09-449D-B9C4-DEC338ADA898Q36761998-1F76777D-BF7C-49EE-88E2-42491DB87451Q37001266-17A43C3B-77F4-4E0B-AE16-1E2A7F904D77Q37251655-D0B7D6E7-43BE-4599-97D8-D30224ACC6DEQ37522587-0DB87AE0-836B-4872-A9AF-D6D185147DBBQ37585848-838DA629-F915-4D60-BEA4-8C36E054832AQ37680397-7F973CA3-7532-4579-B2DD-E06AB4DD8B41Q37817813-33357BCC-5C8B-4D7F-9E04-2EAB546D5C9BQ37922124-86C8BD98-BC63-4C1B-B461-93861C8D4FE7Q37977061-ECA6E3A4-9AD1-4764-92EA-4B4A864D2088Q37977872-4C175E9B-F4D1-4E86-8408-7F1BE84752CBQ38181853-09825CCE-5272-4B18-B42B-56F4924CD021Q38199743-F54B68B2-1185-4FBE-B0BD-2FAF3CC4E054Q38202647-2CBB8693-5695-4DC3-BE2F-E1C35CD34461Q38230626-589F6FC4-927F-4FE3-9C8B-F929A3EE5C63Q38380615-8ADEF163-7483-4A87-93AF-F002ED5B6A05Q38690013-03B355CE-45C2-4E7B-B0A7-F211DFE46627Q39110308-AE152066-A6C4-4807-AAE9-5081AB52AD49
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Prophylaxis strategies for contrast-induced nephropathy
@ast
Prophylaxis strategies for contrast-induced nephropathy
@en
Prophylaxis strategies for contrast-induced nephropathy
@nl
type
label
Prophylaxis strategies for contrast-induced nephropathy
@ast
Prophylaxis strategies for contrast-induced nephropathy
@en
Prophylaxis strategies for contrast-induced nephropathy
@nl
prefLabel
Prophylaxis strategies for contrast-induced nephropathy
@ast
Prophylaxis strategies for contrast-induced nephropathy
@en
Prophylaxis strategies for contrast-induced nephropathy
@nl
P3181
P356
P1476
Prophylaxis strategies for contrast-induced nephropathy
@en
P2093
Neesh Pannu
P304
P3181
P356
10.1001/JAMA.295.23.2765
P407
P577
2006-06-21T00:00:00Z